BioMerieux SA (XPAR:BIM)
€ 98.85 -0.2 (-0.2%) Market Cap: 11.66 Bil Enterprise Value: 11.94 Bil PE Ratio: 28.34 PB Ratio: 3.00 GF Score: 98/100

Q3 2020 Biomerieux SA Business Review Call Transcript

Oct 22, 2020 / 01:00PM GMT
Release Date Price: €127.7 (-3.18%)
Operator

Good day and welcome to the bioMérieux Third Quarter 2020 Business Review Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Franck Admant. Please go ahead.

Franck Admant;rieux S.A.;Director of IR
bioMÃ

©-

Hello. Thank you. Good afternoon, and thank you for joining us to review bioMérieux' performance on the 2020 -- third quarter of 2020. As usual, I am online with Alexandre Mérieux, Chairman and CEO; as well as Guillaume Bouhours, CFO.

Before handing the call over to Alexandre for opening remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer saying that forward-looking statements are based entirely and partially on assessment or judgments that may change or be modified due to uncertainties and risks related to the company's environment, notably those described in the 2018 registration document, including, but not limited to, economic conditions; financial exposure to currency

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot